Neuropsychology of Early‐treated Phenylketonuria: Specific Executive Function Deficits

Child Development

Volumn 61, Issue 6, 1990, Pages 1697-1713

  Welsh, Marilyn C ^a   Pennington, Bruce F ^b   Ozonoff, Sally ^c   Rouse, Bobbye ^d   McCabe, Edward R B ^d  

^a FORDHAM UNIVERSITY   (United States)

^b UNIVERSITY OF DENVER   (United States)

^c UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^d BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHENYLALANINE;

ARTICLE; COGNITIVE DEFECT; DIET THERAPY; FEMALE; FOLLOW UP; HUMAN; INTELLIGENCE; MALE; PHENYLKETONURIA; PRESCHOOL CHILD; PSYCHOLOGICAL ASPECT; URINE;

CHILD, PRESCHOOL; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMAN; INTELLIGENCE; MALE; PHENYLALANINE; PHENYLKETONURIAS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025580566     PISSN: 00093920     EISSN: 14678624     Source Type: Journal    
DOI: 10.1111/j.1467-8624.1990.tb03560.x     Document Type: Article

References (85)

1. Alpha‐adrenergic mechanisms in prefrontal cortex associated with cognitive decline in aged nonhuman primates
2. Intellectual development and academic achievement of children treated early for phenylketonuria
3. The influence of phenylalanine intake on the chemistry and behavior of a phenylketonuric child
4. Tower of Hanoi performance of retarded young adults and nonretarded children as function of solution length and goal state
5. Skills, plans, and self‐regulation
6. Recognition memory for pictures in preschool children
7. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey
8. Early‐treated PKU: Neuropsychologic consequences
9. Neurotransmitter defects and treatment of disorders of hyperphenylalaninemia
10. Termination of dietary treatment in phenylketonuria
11. Monkey retarded learning analysis
12. Observations indicating the nature of the mutation in phenylketonuria
13. Neurological and psychiatric aspects of phenylketonuria
14. Pathogenesis of phenylketonuria: Inhibition of dopa and catecholamine synthesis in patients with phenylketonuria
15. The use of deuterated phenylalanine for the elucidation of the pheynlalanine‐tyrosine metabolism
16. Tight linkage between a splicing mutation and a specific DNA haplotype in phenylketonuria
17. Converging projections from the mediodorsal thalamic nucleus and mesencephalic dopaminergic neurons to the neocortex in three species
18. Intellectual assessment of 111 four‐year‐old children with phenylketonuria
19. Attention and cognitive problems
20. Treated phenylketonuria: Intelligence and blood phenylalanine levels
21. The prefrontal cortex, mediator of cross‐temporal contingencies
22. A standardized version of Luria's neuropsychological tests
23. Effect of dietary phenylalanine restriction on visual attention span in mentally retarded subjects with phenylketonuria
24. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants
25. Dietary problems of phenylketonuria: Effect on CNS transmitters and their possible role in behavior and neuropsychological function
26. Effect of age at loss of dietary control on intellectual performance and behavior of children with phenylketonuria
27. Remodeling old models of intelligence
28. Evaluation of treatment begun in first three months of life in 184 cases of phenylketonuria
29. Formal assessment of problem‐solving and planning processes in preschool children
30. Paired comparisons between early treated PKU children and their matched sibling controls on intelligence and school achievement test results at eight years of age
31. Perceptual‐motor functioning in children with phenylketonuria
32. Phenylalanine alters the mean power frequency of electroencephalograms and plasma L‐dopa in treated patients with phenylketonuria
33. Biochemical and neuropsychological effects of elevated plasma phenylalanine in patients with treated phenylketonuria: A model for the study of phenylalanine and brain function in man
34. Genetic screening
35. Decreased vigilance and neurotransmitter synthesis after discontinuation of dietary treatment of phenylketonuria in adolescents
36. Management of extra pyramidal manifestations of phenylketonuria with L‐dopa
37. Effects of diet and behavior therapy on social and motor behavior of retarded phenylketonuric adults: An experimental analysis
38. Effect of totally synthetic low phenylalanine diet on adolescent phenylketonuric patients
39. The effects of high phenylalanine concentrations on serotonin and catecholamine metabolism in the human brain
40. Linguistic development of children with phenylketonuria and normal intelligence
41. Some effects of frontal lobectomy in man
42. Phenylketonuria and its variants: Observations on intellectual functioning
43. Cognitive development in early‐treated phenylketonuria
44. The variability in manifestations of untreated patients with phenylketonuria (phenylpyruvic aciduria)
45. Neurological deficits in early‐treated phenylketonurics
46. Effects of brain tumor on perception of hidden figures, sorting behavior and problem solving performances
47. Brain stem innervation of prefrontal and anterior cingulate cortex in the rhesus monkey revealed by retrograde transport of HRP
48. A new approach to the treatment of phenylketonuria
49. Phenylketonuria with normal intelligence
50. Procedural learning and neostriatal dysfunction in man
51. Inborn errors and disturbances of central neurotransmission (with special reference to phenylketonuria)
52. Loss of intellectual function in children with PKU
53. Specific impairments of planning
54. The functional equivalence of problem solving skills
55. Information processing in early‐treated PKU
56. A componential approach to intellectual development
57. Neuropsychological studies of the frontal lobes
58. The frontal lobes and control of cognition and memory
59. Frontal lobe dysfunction in Parkinson's disease: The cortical focus of neostriatal outflow
60. Some alterations in behavior after cerebral lesions in man
61. Changes in visual searching performance following cerebral lesions
62. Screening for phenylketonuria
63. Predictors of intelligence quotient and intelligence quotient change in persons treated for phenylketonuria early in life
64. The WAIS as a lateralizing and localizing diagnostic instrument: A study of 656 patients with unilateral lesions
65. Prefrontal CBF during specific cognitive activation: Studies of Huntington's and Parkinson's diseases
66. Effects of penetrating brain injury on intelligence test scores
67. Rule‐guided behavior and self‐monitoring on the Tower of Hanoi disktransfer task
68. Assessing frontal lobe function in children: Views from developmental psychology
69. A normative‐developmental study of executive function: A window on prefrontal function in children
70. Collaborative study of children treated for phenylketonuria: Study design
71. Correlates of intelligence test results in treated phenylketonuric children
72. Molecular basis of phenylketonuria and potential somatic gene therapy
73. Cloned human phenylalanine hydroxylase gene allows prenatal diagnosis and carrier detection of classical phenylketonuria
74. Late onset phenylalanine intoxication